Atorvastatin Calcium
Product Images NDC 43353-120

7 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43353-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10mg (43353 0120 60)

Bottle Label 10mg (43353 0120 60)
Label for Atorvastatin Calcium 10 mg tablets by Aphena Pharma Solutions - Tennessee, LLC. This bottle contains 90 tablets and includes storage instructions and manufacturing information by Pfizer Ireland Pharmaceuticals, Dublin, Ireland. The label indicates the product is prescription only (Rx Only).*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Atorvastatin 01)

Chemical Structure (Atorvastatin 01)
Chemical structure of Atorvastatin Calcium dihydrate, showing the molecular arrangement including aromatic rings, fluorophenyl group, hydroxyl groups, and calcium ion coordination with water molecules.*
FDA Label Image

Figure 1 (Atorvastatin 02)

Figure 1 (Atorvastatin 02)
A line graph comparing cumulative incidence percentages over 3.5 years for Atorvastatin versus Placebo. The graph features two lines, solid for Atorvastatin and dashed for Placebo, illustrating lower cumulative incidence for Atorvastatin. Hazard ratio and p-value are noted on the graph.*
FDA Label Image

Figure 2 (Atorvastatin 03)

Figure 2 (Atorvastatin 03)
A line graph comparing cumulative hazard percentage over time (years) to first primary endpoint for two groups: Placebo and Atorvastatin. The graph shows lower cumulative hazard for Atorvastatin over approximately four years of follow-up, with hazard ratio (HR) 0.63 (0.48-0.83) and p=0.001.*
FDA Label Image

Figure 3 (Atorvastatin 04)

Figure 3 (Atorvastatin 04)
A Kaplan-Meier curve chart illustrating the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years), comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The chart includes a hazard ratio (HR) of 0.78 with a confidence interval (0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Greenstone Logo (Atorvastatin 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.